Thursday, July 12, 2018 8:34:23 AM
https://globenewswire.com/news-release/2018/06/14/1524782/0/en/Recall-Studios-Offers-to-Purchase-Pulse-Evolution-Common-Stock-at-1-38-per-Share.html
"Recall Studios (OTC: “BTOP”) today announced its offer to purchase 100% of the unrestricted and open-market shares of Pulse Evolution Corporation (OTC:”PLFX”) for $1.38 per share. Together with its acquisition of Evolution AI Corporation, which was also announced today, the proposed tender offer would result in Pulse Evolution Corporation becoming a majority-owned subsidiary of Recall Studios, Inc."
Nowhere in this press release does it mention a min-max assumption or the $0.50 per share.
But as investors we can speculate what the deal would be depending on the share price of Recall at the time the tender happens. If the shares are at $0.50 per share, then Recall would have to give 2.76 Recall shares for each 1 share of Pulse to deliver $1.38 in value. If the Recall shares climb to $0.75 per share in the market, then Recall would have to give 1.84 shares of Recall stock to deliver $1.38 per share. And if the bottom falls out of the market for Recall shares and the shares drop to $0.25 per share then Recall has to give 5.5 shares of Recall stock for each share of Pulse stock in order to deliver the $1.38
It's a clear press release. It says $1.38 per pulse share. It's confirmed again in yesterdays press release from Pulse - $1.38
People just need to read the black and white as black and white. Exchange offer math is really simple. It works on the exchange value of $1.38 and regardless of the changes in the Recall stock, the tender offer is at $1.38
People on this board say the market is not buying this deal. The market is also holding the Recall shares pretty stable at $0.45 per share. That's the number that matters to Pulse shareholders - because that means 3 shares of Recall for each Pulse share held.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM